Volume 69, Issue 5, Pages (March 2006)

Slides:

Advertisements

Similar presentations

Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: A long-term prospective evaluation V. La Milia, P. Pozzoni, G. Virga,

Advertisements

Acid-base profile in patients on PD

Home care assistance and the utilization of peritoneal dialysis

A skeptical view of assisted home peritoneal dialysis

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Beta blockers in the management of chronic kidney disease

Volume 69, Issue 5, Pages (March 2006)

Iron status and iron supplementation in peritoneal dialysis patients

Acid-base profile in patients on PD

End-stage renal disease in developing countries

Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis James F. Medcalf, Kevin P.G.

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Volume 64, Pages S3-S12 (December 2003)

Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy G. Viglino, L. Neri, S. Barbieri Kidney.

C-reactive protein and dialysis access

Section 5: Dialysis Interventions for Treatment of AKI

Glucose sparing in peritoneal dialysis: Implications and metrics

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 71, Issue 8, Pages (April 2007)

Volume 73, Issue 4, Pages (February 2008)

Volume 70, Pages S21-S25 (December 2006)

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Volume 78, Issue 6, Pages (September 2010)

V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 73, Pages S5-S17 (April 2008)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure A. Parikova, W. Smit, D.G. Struijk,

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Volume 68, Issue 2, Pages (August 2005)

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function S.L.S. Fan, T. Pile, S. Punzalan, M.J.

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 71, Issue 6, Pages (March 2007)

Profiling of peritoneal ultrafiltration

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Volume 73, Pages S72-S75 (April 2008)

Volume 71, Issue 4, Pages (February 2007)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 71, Issue 12, Pages (June 2007)

A skeptical view of assisted home peritoneal dialysis

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Volume 67, Pages S15-S19 (January 2005)

The valuable contribution of observational studies to nephrology

Peter G. Blake, Arsh K. Jain, Sechelle Yohanna Kidney International

Volume 66, Issue 2, Pages (August 2004)

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 69, Issue 1, Pages (January 2006)

Volume 70, Issue 8, Pages (October 2006)

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 70, Issue 5, Pages (September 2006)

Volume 72, Issue 11, Pages (December 2007)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 58, Issue 5, Pages (November 2000)

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Presentation transcript:

Volume 69, Issue 5, Pages 927-933 (March 2006) Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: A long-term prospective evaluation V. La Milia, P. Pozzoni, G. Virga, M. Crepaldi, L. Del Vecchio, S. Andrulli, F. Locatelli Kidney International Volume 69, Issue 5, Pages 927-933 (March 2006) DOI: 10.1038/sj.ki.5000183 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Flow chart of patients during the study. ‘Still on PD’ patients indicate those who were still on PD therapy at the end of the follow-up. Data are expressed as means±s.d. or as median with inter-quartile range within brackets. Kidney International 2006 69, 927-933DOI: (10.1038/sj.ki.5000183) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Changes of peritoneal transport characteristics in patients with at least two 3.86%-PETs (two PETs) (n=62), at least three 3.86%-PETs (three PETs) (n=42), at least four 3.86%-PETs (four PETs) (n=20), and at least five 3.86%-PETs (five PETs) (n=11). UF: two PETs P=0.671; three PETs P=0.014; four PETs P=0.012; five PETs P=0.114. D/D0: two PETs P=0.464; three PETs P=0.705; four PETs P=0.589; five PETs P=0.057. D/PCreat: two PETs P=0.043; three PETs P=0.142; four PETs P=0.241; five PETs P=0.398. ΔDNa: two PETs P<0.001; three PETs P<0.001; four PETs P<0.001; five PETs P=0.048. Data are expressed as means±s.e. See Tables 1 and 2 for abbreviations. Kidney International 2006 69, 927-933DOI: (10.1038/sj.ki.5000183) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan–Meier curve of proportion of patients with and without UF failure during the follow-up (n=95). Kidney International 2006 69, 927-933DOI: (10.1038/sj.ki.5000183) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Changes of peritoneal transport characteristics between the first and the last PET in patients with (UFF) and without (UFN) UF failure (n=60). Data are shown as means±standard error *P=0.575 vs first PET; *P<0.001 vs UFF; **P<0.001 vs first PET. §P=0.883 vs first PET; §P=0.014 vs UFF; §§P=0.031 vs first PET. °P=0.736 vs first PET; °P=0.046 vs UFF; °°P=0.014 vs first PET. #P<0.001 vs first PET; #P=0.005 vs UFF; ##P=0.006 vs first PET. See Tables 1 and 2 for abbreviations. Kidney International 2006 69, 927-933DOI: (10.1038/sj.ki.5000183) Copyright © 2006 International Society of Nephrology Terms and Conditions